The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The week ending 28/10 was showing many sells at 7.8p as the bid was listed as 8p but those 7.8p transactions were buys as 2 were mine on Friday 28/10. I could not get any quote that week to sell but the following week I could sell many if required. I could see the TR1 coming and did mention it here as TB never wants to lose out on a low offer.
Dyor.
Unfortunately, this could be because they no longer have any working capital left in the bank. Both Autins and Velocity investments are down heavily so I doubt TB will want to show face of ditching anything at a loss. This could be just to keep the lights on until they can get some deal on Phasefocus or until another placing with new investments.
Without TB or Viv coming out and explaining things, we may see the SP drop under the placing amount this week. We just have to hope that it’s TB portraying negativity to buy up more cheap shares but it is worrying indeed.
I have supported Braveheart for the last 2 years and most of that time I have always had a positive feel about things. Unfortunately, this time I feel like we have been led to believe things that aren’t quite what they seem.
Many say from the last RNS that the Covid test is now dead. We all ask why would they let a test that has taken over 1.5 years to develop, told that millions were spent to enhance and complete it just to go and shelf it? Yes I know RNS doesn’t actually say it’s binned and Prof Smythe does say it’s complete and ready.
TB had said since March 2021 he was going to get the test CE & UK equivalent mark. If complete and ready, wouldn’t they already have this?
Who would buy it without?
The test is apparently going through more trials which are aimed to be finished by end of June, it’s a long time from a February update so does it mean TBs attention is now turned to other new investments as per latest GM request?
Last accounts say Phasefocus has an upgraded value but if it’s as quoted £4m that’s still only half of the current MC. Are the other investments really worth another £4m?
The Sepsis test is in the beginning stages as like anything, what realistic chance does it really have of being a World class test against any other company that’s currently designing some other Sepsis test system?
How many years is it likely to take to get this test up and running considering how long the much easier covid test took?
TB is currently holding at a lower SP average than the current SP so he’s not losing anything but looking at this realistically, are we really going to see anything more than 20p a share again?
I have a very large investment in BRH and I’m probably down on paper the price of a UK average 2 bed house but there comes a point where you have to wake up and smell the coffee.
As much as I wanted to believe the dream, it’s been soured with TB and his games…
No one has the facts except for the insiders so it’s my view only. Dyor always.
It appears this message was overlooked by all or none of you are interested. This company are holding £4m in equity and being part of the Braveheart empire would be part of the Market Cap.
Braveheart haven’t really elaborated on any of their non strategic investments but could have a lot of equity hidden in some of them.
dyor.
It’s making sense now. The FAB/TB money will be used for another fleece.
Chamberlin plc (AIM: CMH.L), the specialist castings and engineering group, is pleased to announce that it has conditionally raised £1.8 million (before expenses), pursuant to a placing of 30,133,333 new Ordinary Shares of 0.1p each (the "Placing Shares") at a placing price of 5 pence per share (the "Placing Price") with institutional and other investors (the "Placing") and a subscription for 5,866,667 new Ordinary Shares (the "Subscription Shares") at the Placing Price by Trevor Brown, Executive Director (the "Subscription"), (the Subscription Shares together with the Placing Shares, the "New Ordinary Shares" and the Subscription and the Placing, together, the "Fundraising").
Cenkos Securities plc ("Cenkos Securities") and Peterhouse Capital Limited ("Peterhouse") acted as joint bookrunners to the Placing ("Joint Bookrunners").
The Placing Price represents a discount of 31 per cent. to the closing mid-market price of 7.25 pence per Ordinary Share on 1 February 2022 (being the last practicable date before the release of this announcement).
Dyor
Have a look at this company under the Braveheart umbrella. TB is director, there doesn’t appear to be much happening but if I’m not mistaken it’s holding £4m in equity. This is almost half the current Braveheart MC. Adding all other portfolio investments would show the company to be way undervalue.
https://find-and-update.company-information.service.gov.uk/company/SC109288/officers
Dyor
Guys, no need to panic and certainly don’t listen to the village idiot Proleeeeeeee.
The Autins holding is a dilution that took place on 10th December which diluted any holding by roughly 27 percent. After the placing the shares grew from approx 39.7m to 54.7m. Braveheart held nearly 12 percent which now diluted is around 8.75 percent.
Don’t get spooked about needing cash or selling out as it’s just business as usual.
Dyor.
Why are you worrying about a product that appears to be a ramped toy?
If you research the companies you will find the following..
Kidod Science & Technologies Ltd - https://www.kidodscience.com/
The amateur site could have been made by a child and was first trialled in India to help the government last year, surely it would be Indian? why is there no company address and why is the telephone number an Israel number? An Israeli product that’s not even trialled in its own country? With no links to technical documentation/data. I don’t see any science or research other than a few ramping sentences.
Certsco - the Virion supplier for the UK - https://www.certsco.com
Another amateur site which is run under another company called Communicate Solutions Ltd. If you look at companies house, this is supposed to be a PPE company who have only the minimal accounts like a home setup. They have a Certsco twitter account with no followers or following anyone?
Would the best thing since sliced bread honestly use a company with no sales, account figures under £10k, no staff to promote and sell their product?
Virion doesn’t worry me.
Ok from a little bit of investigation with companies house, Trevor terminated his directorship with Free Association books ltd yesterday.
Now I don’t know if this person is a relation to Trevor : MR MAX CHRISTOPHER VINALL BROWN but he is the new director.
It could be a juggle around for tax reasons but don’t look bad news.
It amazes me how quickly positive comments turn to negative. If you think about this logically, we know Paraytec are working with Sagentia to design and build the testing device that will be manufactured.
I would expect all the potential companies are waiting to see what they come up with before committing to any partnership or buyout. We all know the underlying tech is better than what we are currently seeing on the market and with rapid testing becoming more in demand, the interest will continue until someone brings out a better alternative.
I’m not expecting to see any Paraytec update until next Friday 17th December as this is the last day of semesters at Sheffield University. The university starts again on 17th January so they will want to put an update out probably saying still progressing and more news end of Jan. if you look at RNS’s for last year, you will see they did the same.
The problem with many new shareholders are they watch the market minute by minute all day and expect to bag quickly.
If you don’t have patience then you shouldn’t invest in shares.
Things are moving along as updates have pointed out so if you are a believer, healthy rewards can follow. Market Cap is low and there is definitely value here.
It would be very nice if something big was announced before Christmas so we can celebrate.
This is my view only so dyor.
Notready, it’s not a good way to approach a board telling everyone they are bl**ming idiots. It adds a sense of bitterness to your comments.
TB does only think of himself and did shaft PI’s when selling the SP down and taking the placing at rock bottom to ride it back up again. But one thing TB does know is how to make money and the biggest way to make his next windfall will be to drip feed good news to increase the SP and then launch it on a sale announcement (or at least an offer). If he believes it will go through then the healthy dividend will follow which will fill TB’s & PI’s boots. Plus if a sale happens I see Carl and Sheffield uni although not invested in shares, will be taken care of.
We are all here to make money and the way things are at BRH right now, it looks very positive. All we need is patience.
Guys, as Amagedon says the update for Sepsis and Bladder Cancer came in November included in the interims.
In parallel with the COVID-19 project, Paraytec is working with Professor Carl Smythe's team at the University of Sheffield to restart development of the bladder cancer test, based on the CX300 technology platform. The team has already identified the scientific and engineering teams needed to produce a test for the bacteraemia that causes sepsis and has prepared a detailed plan to produce a prototype instrument.
What more can they say? From what it looks like they will be developing prototypes so hardware wise, it’s basically at a very early stage and I wouldn’t expect anything more until next year.
The important thing will be if during turning the covid test prototype into a manufactured unit, we hear about an offer for the tech or buyout of Paraytec altogether.
Ive seen some comments expecting a dividend. The only reason one was paid back in January was down to the selling of bravehearts investment in RMS. They made £16m and gave most of it back to share holders as a special dividend. This could happen again but only after Paraytec and/or Phasefocus have been sold and sale completed. The RMS sale dividend was much quicker as it was only a sale of shares which is instant when sold.
Things are positive and we don’t really know exactly when Sagentia was instructed to help. TB mentioned developing themselves back in August after the placing so it could have been anytime from then until the announcement.
Patience is required and I can see we will be rewarded over the next year. Don’t expect a quick payout although it would be nice for Christmas.
My take for today…dyor